Shintaro Kanda, Tomonori Mizutani, Shogo Nomura, Yasushi Goto, Gen Kida, Hirokazu Taniguchi, Hiroshi Tanaka, Toshihide Yokoyama, Koichi Azuma, Eiji Iwama, Yukihiro Toi, Ryo Toyozawa, Hidetoshi Hayashi, Haruko Daga, Junichi Shimizu, Yuichiro Ohe, Seiji Niho, Isamu Okamoto. "Five-year outcomes of osimertinib-based treatment in a phase III study comparing EGFR tyrosine kinase inhibitor (EGFR-TKI) monotherapy and EGFR-TKI with inserted cisplatin plus pemetrexed as a first-line treatment for advanced non-squamous non–small-cell lung cancer harboring EGFR mutation (JCOG1404/WJOG8214L).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8649